SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

CIPLA

BSE: 500087 10 Jul 2025
Healthcare
₹ 1492
Cipla Ltd., specializes in Pharmaceuticals within the Healthcare sector.

CIPLA - Share Price & Details

Market Cap
₹1,20,437
High /Low
1,702 / 1,310
Stock P/E
23.4
Book Value
₹386.0
Dividend Yield
0.87
ROCE
22.7
ROE
₹17.8
Face Value
2.0
PEG Ratio
0.79
EVEBITDA
₹15.4
Debt
438
CMP / FCF
43.0
Debt to equity
₹0.01
NP Ann
5,269
High price all time
1,702
Piotroski score
₹7.0
Graham Number
753.0
No. Eq. Shares
80.8
Net CF
₹30.3
Net profit
5,269
Price to book value
3.83
Interest Coverage
₹108.0
Low price all time
84.7
Industry PE
33.4
Reserves
₹31,032
Free Cash Flow
₹3,490

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.18259.0
Triochem Products Ltd.,NANANANA0
CIPLA LTD.70191.512141.467296.915.121,20,43723.4
TORRENT PHARMACEUTICALS LTD.24480.04740.024330.01411280958.9
APOLLO HOSPITALS ENTERPRISE LTNANANANA10755474.4

Peer Comparison Chart


About CIPLA

Cipla Ltd.,, with Security Code 500087, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Nifty 50 top gainers: HUL shares gain 1.44%; Asian Paints, Cipla stocks also rise

(09 Jul 2025)
HUL, Asian Paints and Cipla were trading positively in Wednesday's session.
Read more →

Cipla share price falls 2.01% in Tuesday's trading session

(08 Jul 2025)
With the stock currently trading at Rs 1480.20, Cipla reflects investor reactions to both market dynamics and company-specific...
Read more →

Inside Cipla’s battle with ‘superbugs’ as antibiotic resistance rises in India | Company Business News

(04 Jul 2025)
'Superbugs' render existing treatments ineffective and can worsen an infection, even causing death.
Read more →

Cipla faces revenue and margin pressure ahead of Revlimid patent expiry

(04 Jul 2025)
ET Intelligence Group: Cipla has underperformed the sector indices in the past twelve months following expected pressure on revenue and...
Read more →

Cipla exploring new customer deals for its China factory: Executive

(04 Jul 2025)
Shanghai: Indian pharmaceutical giant Cipla is exploring entry into at least two new international markets for products manufactured at its...
Read more →

Five Stocks To Buy: Tata Communications, Federal Bank, Cipla Among Others

(02 Jul 2025)
Tata Communications Ltd., CESC Ltd., Federal Bank Ltd., Cipla Ltd., and Bank of Baroda Ltd. are among stock with 'buy' recommendations this...
Read more →

Company Updates